Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-06

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating infusion of umbilical cord-derived mesenchymal stem cells for diabetes-related vascular complications, including peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Jie Shen | Conditions: Peripheral Vascular Disease, Ischemia | Phase 1 | Status: UNKNOWN